Phillip M. Satow is Director at NOVEN PHARMACEUTICALS INC (NOVN). They have made 1 open-market trade across 1 company since 2008, most recently 2009-08-27.
CIK 0001224338
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $282K since 2008, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NOVN | 9,120 | $858 |
Shares reported on the most recent Form 4, priced at the 2009-08-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NOVN | BUY | 2008-06-13 | 2008-06-16 | $11.28 | $282K | +40.1% | +25.7% | +25.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.